Last reviewed · How we verify

Ethinone — Competitive Intelligence Brief

Ethinone (ETHISTERONE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: ethisterone. Area: Other.

phase 3 ethisterone Sex hormone-binding globulin, Glucocorticoid receptor, Androgen receptor Other Small molecule Live · refreshed every 30 min

Target snapshot

Ethinone (ETHISTERONE). Ethinone works by binding to sex hormone-binding globulin, affecting the levels of sex hormones in the body.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ethinone TARGET ETHISTERONE phase 3 ethisterone Sex hormone-binding globulin, Glucocorticoid receptor, Androgen receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (ethisterone class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ethinone — Competitive Intelligence Brief. https://druglandscape.com/ci/ethisterone. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing